Risikofaktoren für COVID-19-Mortalität

Keine Erkrankung hat in den letzten Jahrzehnten die Welt innerhalb kürzester Zeit so nachhaltig verändert wie COVID-19. Innerhalb weniger Wochen sahen wir uns mit einem Erreger konfrontiert, der nicht nur hochinfektiös, sondern potenziell auch mit einer hohen Mortalität vergesellschaftet war. Nahezu alle Gesundheitssysteme wurden während der 2 Jahre der Pandemie an die Grenzen ihrer Leistungsfähigkeit geführt oder überschritten diese deutlich.

Abstract

The COVID-19 pandemic has changed the world significantly within the last two years and has put a major burden on health care systems worldwide. Due to the imbalance between the number of patients requiring treatment and the shortage of necessary healthcare resources, a new mode of triage had to be established. The allocation of resources and definition of treatment priorities could be supported by taking the actual short-term mortality risk of patients with COVID-19 into account. We therefore analyzed the current literature for criteria to predict mortality in COVID-19.

Schlüsselwörter

COVID-19 - Mortalität - Risikofaktoren - Triage - Prädiktion

Keywords

COVID-19 - mortality - risc factors - triage - prediction

• Literatur

• 1 Streckbein S, Kohlmann T, Luxen J. et al. Sichtungskonzepte bei Massenanfällen von Verletzten und Erkrankten: Ein Überblick 30 Jahre nach START. Unfallchirurg 2016; 119: 620-631
• 2 Truog RD, Mitchell C, Daley GQ. The Toughest Triage — Allocating Ventilators in a Pandemic. N Engl J Med 2020; 382: 1973-1975
• 3 Buoro S, Di Marco F, Rizzi M. et al. Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront…. Int J Lab Hematol 2020; 42: 8-10
• 4 Marckmann G, Neitzke G, Schildmann J. et al. Entscheidungen über die Zuteilung intensivmedizinischer Ressourcen im Kontext der COVID-19-Pandemie: Klinisch-ethische Empfehlungen der DIVI, der DGINA, der DGAI, der DGIIN, der DGNI, der DGP, der DGP und der AEM. Med Klin Intensivmed Notfmed 2020; 115: 477-485
• 5 Bundesgesundheitsministerium. Kabinett beschließt Regelungen zur Triage. Zugriff am 20. November 2022 unter: www.bundesgesundheitsministerium.de/presse/pressemitteilungen/kabinett-beschliesst-regelungen-zur-triage.html
• 6 de Jong VMT, Rousset RZ, Antonio-Villa NE. et al. Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis. BMJ 2022; 378: e069881
• 7 Knight SR, Ho A, Pius R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ 2020; 370: m3339
• 8 Wang K, Zuo P, Liu Y. et al. Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, China. Clin Infect Dis 2020; 71: 2079-2088
• 9 Tai W, He L, Zhang X. et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 2020; 17: 613-620
• 10 Jin Y, Yang H, Ji W. et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020; 12: 372
• 11 Wallentin L, Lindbäck J, Eriksson N. et al. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J 2020; 41: 4037-4046
• 12 Hendren NS, de Lemos JA, Ayers C. et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19. Circulation 2021; 143: 135-144
• 13 Goodman KE, Magder LS, Baghdadi JD. et al. Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66646 Inpatients Across 613 U.S. Hospitals. Clin Infect Dis 2021; 73: e4113-e4123
• 14 Moreira A, Chorath K, Rajasekaran K. et al. Demographic predictors of hospitalization and mortality in US children with COVID-19. Eur J Pediatr 2021; 180: 1659-1663
• 15 Zhang J-J, Dong X, Cao Y-Y. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75: 1730-1741
• 16 Tang N, Li D, Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844-847
• 17 Weber GM, Hong C, Xia Z. et al. International comparisons of laboratory values from the 4 CE collaborative to predict COVID-19 mortality. NPJ Digit Med 2022; 5: 74
• 18 Li X, Shen C, Wang L. et al. Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study. Respir Res 2021; 22: 203
• 19 Wu X, Liu X, Zhou Y. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9: 747-754
• 20 Basheer M, Saad E, Kananeh M. et al. Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?. Curr Issues Mol Biol 2022; 44: 4735-4747
• 21 Zhao J, Yang Y, Huang H. et al. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin Infect Dis 2021; 73: 328-331
• 22 Efat A, Shoeib S, ElKholy A. et al. Blood phenotype O and indirect bilirubin are associated with lower, early COVID-19-related mortality: A retrospective study. Int J Immunopathol Pharmacol 2022; 36: 3946320221133952
• 23 Khalil A, Feghali R, Hassoun M. The Lebanese COVID-19 Cohort; A Challenge for the ABO Blood Group System. Front Med (Lausanne) 2020; 7: 585341
• 24 Muñiz-Diaz E, Llopis J, Parra R. et al. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfus 2021; 19: 54-63
• 25 Shibeeb S, Khan A. ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review. Hematol Transfus Cell Ther 2022; 44: 70-75
• 26 Takagi H. Down the Rabbit-Hole of blood groups and COVID-19. Br J Haematol 2020; 190: e268-e270
• 27 Bardakci O, Daş M, Akdur G. et al. Point-of-care Lung Ultrasound, Lung CT and NEWS to Predict Adverse Outcomes and Mortality in COVID-19 Associated Pneumonia. J Intensive Care Med 2022; 37: 1614-1624
• 28 Abbasi B, Akhavan R, Ghamari Khameneh A. et al. Evaluation of the relationship between inpatient COVID-19 mortality and chest CT severity score. Am J Emerg Med 2021; 45: 458-463
• 29 Xu Y, Trivedi A, Becker N. et al. Machine learning-based derivation and external validation of a tool to predict death and development of organ failure in hospitalized patients with COVID-19. Sci Rep 2022; 12: 16913